SCHEMBL26933818

SCHEMBL26933818

O=C(N[C@@H]1CCNC1)N1CCN(Cc2ccc(F)cc2)c2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 2/20 0.45
▸ HSD11B1 P28845 1/20 0.42
▸ SIGMAR1 Q99720 5/20 0.42
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ MCHR1 Q99705 2/20 0.40
▸ SLC6A12 P48065 1/20 0.40
▸ TMEM97 Q5BJF2 1/20 0.40
▸ ALOX5 P09917 1/20 0.39
▸ EPHX2 P34913 1/20 0.39
▸ GPBAR1 Q8TDU6 1/20 0.39
▸ NR4A2 P43354 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ DRD2 P14416 1/20 0.39
▸ DRD4 P21917 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ PRKAA2 P54646 1/20 0.39
▸ CCR3 P51677 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30673662 1.00 BRD4 (0.45) BRD4HSD11B1SIGMAR1HDAC1HDAC6
SCHEMBL26933826 1.00 BRD4 (0.45) BRD4HSD11B1SIGMAR1HDAC1HDAC6
SCHEMBL26933764 0.94 BRD4 (0.46) BRD4HSD11B1SIGMAR1HDAC1HDAC6
SCHEMBL26933784 0.92 BRD4 (0.54) BRD4HSD11B1SIGMAR1HDAC1HDAC6
SCHEMBL26933787 0.92 BRD4 (0.54) BRD4HSD11B1SIGMAR1HDAC1HDAC6
SCHEMBL30673689 0.92 BRD4 (0.54) BRD4HSD11B1SIGMAR1HDAC1HDAC6
SCHEMBL30673859 0.91 BRD4 (0.46) BRD4HSD11B1SIGMAR1HDAC1HDAC6
SCHEMBL30673737 0.91 BRD4 (0.46) BRD4HSD11B1SIGMAR1HDAC1HDAC6
SCHEMBL30673791 0.89 BRD4 (0.46) BRD4HSD11B1SIGMAR1HDAC1HDAC6
SCHEMBL30673921 0.86 SMN1; SMN2 (0.46) BRD4SIGMAR1CHRM1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4538270-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT Sapiensbio Inc. (KR) 2025-04-16 — — EP claimed
EP-4538270-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT Sapiensbio Inc. (KR) 2025-04-16 — — EP disclosed
WO-2023239227-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT 주식회사 사피엔스바이오 2023-12-14 — — WO disclosed
Send feedback